SCM
IMMU

Sigma Capital Management’s Immunomedics Inc IMMU Stock Holding History

Sigma Capital Management’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-150,000
Closed -$690K – 222
2013
Q4 		$690K Sell
150,000
-1,225,000
-89% -$5.45M 0.04% 147
2013
Q3 		$8.51M Buy
+1,375,000
New +$7.92M 0.36% 83

Other funds holding IMMU

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sigma Capital Management's IMMU Position: Q1 2014 in Review

Sigma Capital Management sold out of Immunomedics Inc (IMMU) in Q1 2014, closing a stake of 150,000 shares — an estimated $690K sold.

Sigma Capital Management first reported a position in IMMU in Q3 2013 and held it in 2 quarters. The position peaked at $8.51M in Q3 2013. 75 funds tracked by Wall St. Rank hold IMMU as of Q1 2014.

  • Sigma Capital Management reported no remaining Immunomedics Inc position as of Q1 2014 after selling out during the quarter.
  • Sigma Capital Management sold 150,000 Immunomedics Inc shares in Q1 2014, an estimated $690K.
  • Sigma Capital Management first reported a position in Immunomedics Inc in Q3 2013 and held it in 2 quarters.
  • Sigma Capital Management's Immunomedics Inc position peaked at $8.51M in Q3 2013.
  • 75 funds tracked by Wall St. Rank held Immunomedics Inc as of Q1 2014.

Based on Sigma Capital Management's 13F filing for Q1 2014, filed 15 May 2014.